于许多人，体检并不陌生，但如何理解体检报告，却始终是一个难题。而 AI 的发展，带来了全新的可能：它可以承担翻译、分析与陪伴 的多重角色，将专业医学信息转化为普通人可以理解和使用的内容。 正是基于这一背景， 3 月 23 日，美年健康与蚂蚁阿福宣布达成战略合作， 双方将围绕体检、报告解读、检后问诊、用药的健康服务全 链条展开深度探索 。作为首期成果，美年健康 AI 助手 " 健康小美 " 入驻阿福 App ，用户在授权后即可一键查询近三年体检报告，并获 得免费、专业的 AI 解读。 作为以 AI 赋能健康管理行业的重要尝试，这项合作让体检不再停留在检查与报告层面，而是进入持续发挥作用的健康管理过程，并为后 续更全面、个性化的健康服务建 立基础。 对于双方合作，资本市场也给出积极反馈。截至3月24日收盘，美年健康（002044.SZ）报收5.60元，上涨3.32%，盘中最高触及5.73 元，全天成交额达5.93亿元，换手率2.74%，成交量突破106万手。 体检不该止于报告 体检报告长期以来的一个核心问题，在于专业医学语言与普通用户之间的错位。当理解门槛过高，人们要么容易陷入不必要的焦虑，要么 可能忽视甚至搁置 ...

每年体检季，无数人都会面临同样的困境：攥着一份布满箭头和医学术语的报告，要么焦虑地四 处挂号，要么索性将其束之高阁，直到下一年的体检单再次敲响警钟。体检，这个本该是健康管 理起点的行为，却实际成为了"一次性"的例行公事。 3月2 3日，这一局面迎来了破局者。国内领先的健康管理服务机构美年健康与国民级健康AI应 用蚂蚁阿福宣布达成全面战略合作，将AI与体检报告、检后服务串联起来，撬动一个从"单次 体检"到"持续健康管理"的全新时代。 美年健康董事长俞熔表示，此次美年健康与蚂蚁阿福的战略合作是AI健康基础设施与国民健 康AI入口的深度联动、双向赋能，为医疗健康服务开启了全新的可能性。这并非仅仅是线上 与线下的简单对接，更是专业健康与国民科技的深度融合。其背后体现的是合作双方美年健 康与蚂蚁阿福的深度交融。 "此次合作，真正实现线上AI咨询、线下体检履约以及检后全周期管理的医疗服务闭环。"俞 熔指出。 当美年健康的专业体检网络与蚂蚁阿福的亿级健康AI入口深度融合，一场关于健康服务模式 的深刻变革已然开启。 体检报告不再"高冷" "这报告上的箭头到底代表什么？我这病严重吗？"这或许是每一位体检用户拿到报告后最本 能的 ...

证券代码：002044 证券简称：美年健康 公告编号：2026-017 美年大健康产业控股股份有限公司 关于公司及下属子公司提供担保的进展公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 二、进展情况 近日，公司与中国光大银行股份有限公司武汉分行（以下简称"光大银行武 汉分行"）签署了《最高额保证合同》，为武汉美年大健康体检管理有限公司（以 下简称"武汉美年"）提供主债权最高本金余额人民币 2,000 万元的连带责任担保。 公司与中国光大银行股份有限公司济南分行（以下简称"光大银行济南分行"） 签署了《最高额保证合同》，为山东慈铭健康体检管理有限公司（以下简称"山 东慈铭"）提供主债权最高本金余额人民币 1,000 万元的连带责任担保。 公司与华夏银行股份有限公司成都分行（以下简称"华夏银行"）签署了《最 高额保证合同》，为成都金牛美年大健康管理咨询有限公司（以下简称"成都金 牛美年"）提供最高债权额人民币 1,000 万元的连带责任担保。 公司与北京银行股份有限公司南昌分行（以下简称"北京银行"）签署了《保 证合同》，为南昌美年大健康长庚健康体检中心有限 ...

Investment Rating - The report does not explicitly state an investment rating for the industry Core Insights - The era of AI in healthcare is approaching, and learning from overseas development models is necessary [5] - AI products in healthcare face obstacles in data exchange, regulatory clarity, and payment systems, with the U.S. leading in data sharing and regulatory frameworks [6] - Investment opportunities in AI healthcare are centered around data resources, platforms, and clear C-end application scenarios [6] Summary by Sections Introduction - The rapid development of large model technologies, represented by Transformers, significantly impacts the healthcare industry, showing disruptive potential across various stakeholders [15] Overseas AI Healthcare Ecosystem Progress - The U.S. has established a smooth data exchange system and a regulatory framework for AI products, with a cautious approach to including AI products in insurance payment systems [6][27] - The report highlights the need for studying overseas data sharing mechanisms and regulatory policies to inform domestic AI healthcare companies [27] Investment Insights and Recommendations - Key investment lines include data asset foundations, data resource platforms, and C-end application companies with clear scenarios [6] - Notable companies to watch include: - Data asset foundations: Chuangshihui Kang, Weining Health, Wanda Information, Jiahe Meikang - Data resource platforms: Meinian Health, Jinyu Medical, Dian Diagnosis - C-end application companies: Yimaitong, Alibaba Health, JD Health [6] Regulatory and Payment Frameworks - The report discusses the evolving regulatory landscape for AI products, emphasizing the need for adaptive regulations that ensure patient safety while encouraging innovation [46] - In the U.S., over 1,400 AI products have received FDA approval, but only a few have been included in insurance reimbursement frameworks [48] - The report notes that domestic payment policies for AI products are still in exploration, with a focus on imaging products [55]

Core Insights - Alibaba Health and Meinian Health signed a strategic cooperation agreement to enhance nursing services and improve user experience through standardized and intelligent home care systems [1][2] Group 1: Collaboration Details - The partnership focuses on three core areas: nursing service collaboration, online and offline resource integration, and pharmaceutical health linkage [1] - Alibaba Health will connect with Meinian Health's professional nursing team to create a 30-minute health service circle, offering home services for chronic disease management, rehabilitation care, and post-operative dressing changes [1] - Both companies will unify service standards through online and offline training, with Meinian Health providing exclusive benefits to Alibaba Health users [1] Group 2: Business Model Innovation - The collaboration aims to establish a service loop that connects health check-ups with online medication purchases, facilitating a process of "identifying issues through check-ups, resolving them online, and following up with nursing care" [1] - The companies will explore innovative business models and jointly develop new insurance products that integrate preventive screening and health protection [1] Group 3: Leadership Perspectives - Alibaba Health's CEO emphasized that AI enhances information accessibility, allowing users to obtain medical information more efficiently and encouraging a shift of some medical services from hospitals to home settings [2] - Meinian Health's Chairman stated the company's transition from a preventive medicine leader to an "AI-driven platform health management technology company," aiming to create personalized services and a comprehensive growth model [2]

Core Viewpoint - The strategic partnership between Alibaba Health and Meinian Health aims to enhance home nursing services through digital transformation in the healthcare sector, focusing on accessibility and user experience [1][2]. Group 1: Collaboration Details - The partnership will focus on three core areas: nursing service collaboration, operational integration, and business closure [2]. - Alibaba Health will connect with Meinian Health's professional nursing team to create a 30-minute health service circle, offering home services for chronic disease management, rehabilitation care, and post-operative dressing changes [2]. - Both companies will unify service standards through online and offline training, with Meinian Health providing exclusive benefits to Alibaba Health users [2]. Group 2: Resource Complementation - Alibaba Health is a leading internet healthcare platform with strong online service capabilities, leveraging user insights to match services for post-examination recovery, medication, and nursing needs [2][3]. - Meinian Health has served nearly 300 million people since its listing in 2015, conducting about 30 million health check-ups annually and maintaining nearly 600 offline health check centers, accumulating extensive multimodal health data [3]. - The collaboration aims to transform Meinian Health's capabilities from primarily serving health check scenarios to supporting home nursing services with critical medical data [3]. Group 3: Leadership Insights - Alibaba Health's CEO highlighted the impact of AI on information accessibility and the shift of some medical services from hospitals to home settings, indicating a growing user willingness for convenient healthcare solutions [3]. - Meinian Health's Chairman emphasized the partnership's goal to make professional health services more accessible and to transition the company into an AI-driven health management technology platform [3].

Core Viewpoint - The strategic partnership between Meinian Health and Alibaba Health aims to enhance home nursing services through collaboration in three key areas: nursing service synergy, online-offline resource integration, and medical health linkage, thereby improving service accessibility and user experience in the healthcare industry [1][6]. Group 1: Collaboration Details - The partnership will focus on three core areas: nursing services, operational standardization, and business closure. Alibaba Health will connect its online services with Meinian Health's professional nursing team to provide home services for chronic disease management, rehabilitation care, and post-operative dressing changes [3][8]. - Both companies will implement unified service standards through online-offline training and provide exclusive benefits to Alibaba Health users from Meinian Health [3][8]. - The collaboration will create a closed-loop service model that integrates health check-ups with online medication purchases, facilitating a seamless process from problem identification to recovery follow-up [3][8]. Group 2: Resource Complementation - Meinian Health is a leader in digital health management, having served nearly 300 million people since its listing in 2015, with an annual health check volume of approximately 30 million and nearly 600 offline health check centers [4][9]. - The collaboration will leverage Meinian's extensive health data and resources to support home nursing services, transitioning from traditional health check scenarios to a more comprehensive care model [4][9]. - Alibaba Health, as a leading internet healthcare platform, will utilize its digital capabilities to identify user needs post-health check and match them with appropriate services [4][9]. Group 3: Service Innovation - The partnership aims to establish a "30-minute health service circle," enabling home health services without the need for users to leave their homes [5][10]. - The integration of health check data, home monitoring data, and AI health management will facilitate personalized health management and risk alerts, transforming traditional health check services into a proactive health management model [5][10]. - The operational model combines Alibaba Health's platform capabilities with Meinian Health's nursing resources, focusing on efficient implementation, standardized execution, and risk control [5][10].

证券代码：002044 证券简称：美年健康 公告编号：2026-016 美年大健康产业控股股份有限公司 美年大健康产业控股股份有限公司（以下简称"公司"）拟通过发行股份的方 式购买交易对方持有的衡阳美年健康体检中心有限公司 84.00%股权、宁德美年 大健康管理有限公司 81.00%股权、烟台美年大健康体检管理有限公司 75.00%股 权、烟台美年福田健康体检管理有限公司 49.00%股权、武汉美慈奥亚科技管理 有限公司 52.81%股权、三明美年大健康管理有限公司 85.00%股权、肥城美年健 康管理有限公司 90.00%股权、德州美年大健康体检管理有限公司 84.00%股权、 连江美年大健康管理有限公司 82.00%股权、沂水美年大健康体检管理有限公司 80.50%股权、山东美铭奥亚健康咨询有限公司 92.35%股权及公司控股子公司郑 州美健健康管理有限公司 47.37%少数股权、广州花都区美年大健康管理有限公 司 49.00%少数股权、安徽美欣健康管理咨询有限公司 42.46%少数股权、淄博美 年大健康管理有限公司 49.00%少数股权、吉林市昌邑区美年大健康科技管理有 限公司 48.05%少数股权（以 ...

Investment Rating - The industry investment rating is "Positive" (maintained) [2] Core Viewpoints - The report emphasizes three main themes: Coding, Agent, and AIGC multimodal, which are expected to thrive despite market volatility [2] - Long-term investment opportunities are identified in companies like Alibaba, Tencent, Kuaishou, and Bilibili, which are expected to rebound after the current market fluctuations [2] - Short-term fluctuations in stock prices are noted, particularly influenced by external factors and market sentiment regarding AI applications [2] - The report highlights the competitive landscape in the Agent sector and the potential for growth in the AIGC multimodal space, particularly with the introduction of new models and applications [2] Summary by Sections Market Performance - The Shenwan Media Index experienced a weekly decline of 5.10%, while the Shanghai Composite Index rose by 1.98% during the same period [2] - The report notes significant volatility in the market, influenced by external factors and the "AI consumption theory" in the US stock market [2] Key Companies and Opportunities - Companies such as Kunlun Wanwei, Perfect World, and Kayi Network are highlighted as key stocks for March, with expectations of strong performance based on their upcoming projects and market positioning [2] - Kunlun Wanwei is noted for its comprehensive AI application strategy and significant revenue potential from short video content [2] - Perfect World is expected to exceed pre-launch reservation numbers for its new game, indicating strong market interest [2] - Kayi Network is anticipated to launch an AI-native social application, which could enhance its market presence [2] Industry Trends - The report discusses the robust performance of domestic AI models and their revenue elasticity, indicating a positive outlook for the sector [2] - The introduction of new multimodal models, such as Google's NanoBanana2, is expected to further advance the industry [2] - The report suggests that the competition among major domestic companies in the Agent sector is intensifying, creating new market opportunities [2]

登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：002044 证券简称：美年健康 公告编号：2026-012 美年大健康产业控股股份有限公司 第九届董事会第十八次（临时）会议 决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导性陈述或重大遗 漏。 一、董事会会议召开情况 美年大健康产业控股股份有限公司（以下简称"公司"）第九届董事会第十八次（临时）会议于2026年2 月13日以电子发送等形式发出会议通知，会议于2026年2月26日上午10时以通讯结合书面审议方式召 开。应出席本次会议的董事为9名，实际出席会议的董事为9名。会议由公司董事长俞熔先生主持，高级 管理人员列席了会议。本次会议的出席人数、召开表决程序、议事内容均符合《中华人民共和国公司 法》和《公司章程》等有关规定。 二、董事会会议审议情况 （一）审议并通过《关于批准本次交易相关的加期审计报告、备考审阅报告的议案》 鉴于本次交易相关文件中经审计的财务数据有效期届满，根据《中华人民共和国公司法》《中华人民共 和国证券法》《上市公司重大资产重组管理办法》《上市公司监管指引第9号一一上市公司筹划和实施 重大资 ...